Recombinant Human GCGR Protein，His

Glucagon receptor (GCGR) is a key player in glucose metabolism and is primarily involved in regulating glucose levels in the blood. Its role in the pathophysiology of diabetes and related metabolic disorders has sparked significant scientific interest. GCGR is a member of the class B G-protein coupled receptor family, and its activation by glucagon leads to an increase in hepatic glucose production, which is critical for maintaining energy homeostasis. Therefore, understanding the structure and function of GCGR is essential for developing therapeutic strategies targeting diabetes and hypoglycemia. Recent advancements in recombinant protein technology have facilitated the production of GCGR in heterologous systems, enabling detailed studies of its biochemical properties, ligand-binding dynamics, and signaling pathways. This research is crucial for elucidating GCGR's role in glucose regulation and for the discovery of novel medications that can modulate its activity to improve glycemic control in diabetic patients. Furthermore, characterized GCGR recombinant proteins serve as vital tools in drug development, aiding in the design of analogs and antagonists that could potentially lead to innovative treatments for metabolic diseases. Overall, the exploration of GCGR’s structural biology and signaling mechanisms continues to be a prominent focus within metabolic research, promising to yield significant insights into new therapeutic avenues.